When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...
Earlier in December 2025, Recursion Pharmaceuticals reported positive Phase 1b/2 TUPELO trial data for REC-4881 in familial adenomatous polyposis, showing rapid and durable reductions in polyp burden ...
The Marshalltown Generating Station, owned by Alliant Energy, hums in Marshalltown in September 2025. A second power plant, the Bobcat Energy Center, will be built near the Marshalltown Generating ...
Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...
Recursion Pharmaceuticals Inc (NASDAQ: RXRX) shares moved higher Wednesday after JPMorgan upgraded the stock to Overweight from Neutral and lifted its price target to $11 from $10. What Happened: ...
BREWSTER, Wash. – A physician from Brewster, has pleaded guilty to charges of adulterating and misbranding medical devices with the intent to defraud or mislead, according to the United States ...
Purchasing power refers to the quantity of goods or services $20 can buy today. Inflation erodes purchasing power, making $10 buy fewer loaves of bread over 10 years. Investing in S&P 500 funds can ...
If the Department of Justice (DOJ) wanted to release every Jeffrey Epstein-related document they had on file, they had the firepower to do so, a former assistant U.S. attorney argued. The DOJ has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback